AU663066B2 - Compounds that inhibit complement and/or suppress immune activity - Google Patents

Compounds that inhibit complement and/or suppress immune activity

Info

Publication number
AU663066B2
AU663066B2 AU91274/91A AU9127491A AU663066B2 AU 663066 B2 AU663066 B2 AU 663066B2 AU 91274/91 A AU91274/91 A AU 91274/91A AU 9127491 A AU9127491 A AU 9127491A AU 663066 B2 AU663066 B2 AU 663066B2
Authority
AU
Australia
Prior art keywords
group
benzofuran
cyclohexane
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU91274/91A
Other languages
English (en)
Other versions
AU9127491A (en
Inventor
Barton J. Bradbury
Stephen H. Ip
Teodoro S. Kaufman
Chew Lee
Henry C. Marsh Jr.
Robert D. Sindelar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Mississippi
Celldex Therapeutics Inc
Original Assignee
T Cell Sciences Inc
University of Mississippi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Cell Sciences Inc, University of Mississippi filed Critical T Cell Sciences Inc
Publication of AU9127491A publication Critical patent/AU9127491A/en
Application granted granted Critical
Publication of AU663066B2 publication Critical patent/AU663066B2/en
Assigned to UNIVERSITY OF MISSISSIPPI, THE, AVANT IMMUNOTHERAPEUTICS, INC. reassignment UNIVERSITY OF MISSISSIPPI, THE Request to Amend Deed and Register Assignors: T CELL SCIENCES, INC., UNIVERSITY OF MISSISSIPPI, THE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU91274/91A 1990-12-06 1991-12-06 Compounds that inhibit complement and/or suppress immune activity Ceased AU663066B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US623849 1990-12-06
US07/623,849 US5366986A (en) 1988-04-15 1990-12-06 Compounds which inhibit complement and/or suppress immune activity
PCT/US1991/009303 WO1992010096A1 (en) 1990-12-06 1991-12-06 Compounds that inhibit complement and/or suppress immune activity

Publications (2)

Publication Number Publication Date
AU9127491A AU9127491A (en) 1992-07-08
AU663066B2 true AU663066B2 (en) 1995-09-28

Family

ID=24499627

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91274/91A Ceased AU663066B2 (en) 1990-12-06 1991-12-06 Compounds that inhibit complement and/or suppress immune activity

Country Status (7)

Country Link
US (2) US5366986A (enExample)
EP (1) EP0561989A1 (enExample)
JP (1) JPH06503829A (enExample)
KR (1) KR100187327B1 (enExample)
AU (1) AU663066B2 (enExample)
CA (1) CA2097826A1 (enExample)
WO (1) WO1992010096A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366986A (en) * 1988-04-15 1994-11-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
US5506247A (en) * 1988-04-15 1996-04-09 T Cell Sciences, Inc. Compounds that inhibit complement and/or suppress immune activity
EP0751787B1 (en) * 1994-03-23 2005-01-12 Alexion Pharmaceuticals, Inc. Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation
US6514996B2 (en) 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
AU705690B2 (en) * 1995-05-19 1999-05-27 Kyowa Hakko Kogyo Co. Ltd. Oxygen-containing heterocyclic compounds
JPH11349488A (ja) * 1998-06-01 1999-12-21 Hisamitsu Pharmaceut Co Inc クラスタリンを含有する免疫抑制剤
US6673154B1 (en) * 2001-06-28 2004-01-06 Advanced Cardiovascular Systems, Inc. Stent mounting device to coat a stent
SE0202133D0 (sv) 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
SE0302755D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel compounds
SE0303090D0 (sv) 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303541D0 (sv) 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
JP2006175744A (ja) * 2004-12-22 2006-07-06 Canon Inc 記録装置、及び記録方法
CN113185383B (zh) * 2021-04-28 2022-07-12 福州大学 一种以柠檬烯环氧化物为加氢受体的香芹酚制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6234486A (en) * 1985-09-05 1987-03-12 Hoechst-Roussel Pharmaceuticals Inc. Spiro(benzofuran-2(3h), 1'-cycloheptane)s
AU564232B2 (en) * 1981-10-19 1987-08-06 Hoechst-Roussel Pharmaceuticals Inc. 2:-substituted-spiro benzofuran(2,1:) cycloalkanes
AU605818B2 (en) * 1986-12-27 1991-01-24 Takeda Chemical Industries Ltd. Coumarane derivatives, their production and use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128286A (en) * 1964-04-07 Process for preparing analogues
CH394240A (de) * 1960-02-12 1965-06-30 Hoffmann La Roche Verfahren zur Herstellung von spirozyklischen Ketoalkoholen
US4035509A (en) * 1974-04-22 1977-07-12 Syntex (U.S.A.) Inc. Methods and compositions for the use of 2-carboxy-5-oxo-5H-dibenzo[a,d]cycloheptenes, salts and esters thereof
FR2405941A1 (fr) * 1977-06-30 1979-05-11 Otsuka Pharma Co Ltd Nouveaux derives sesquiterpeniques utiles notamment comme inhibiteurs du systeme complementaire et leurs procedes de preparation
JPS5492680A (en) * 1977-12-29 1979-07-23 Otsuka Pharmaceut Co Ltd Novel microorganism
JPS589114B2 (ja) * 1977-06-30 1983-02-18 大塚製薬株式会社 セスキテルペン類縁体、その製造法及び腎炎治療剤
JPS5936913B2 (ja) * 1978-02-10 1984-09-06 大塚製薬株式会社 セスキテルペン誘導体
JPS6030289B2 (ja) * 1977-08-30 1985-07-16 大塚製薬株式会社 制ガン剤
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
JPS5630917A (en) * 1979-08-22 1981-03-28 Otsuka Pharmaceut Co Ltd Preventive and remedy for hepatitis
US4263317A (en) * 1979-09-06 1981-04-21 Hoechst-Roussel Pharmaceuticals, Inc. Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s
US4301292A (en) * 1979-09-06 1981-11-17 Hoechst-Roussel Pharmaceuticals, Incorporated 1-[2-(4,5-Dihydro-4,4-dialkyl-2-oxazolyl)phenyl]-4-(dialkylamino)cyclohexanol
JPS5822194B2 (ja) * 1981-09-14 1983-05-07 大塚製薬株式会社 新規な微生物
JPS5822193B2 (ja) * 1981-09-14 1983-05-07 大塚製薬株式会社 新規な微生物
US4404221A (en) * 1981-10-19 1983-09-13 Hoechst-Roussel Pharmaceuticals Inc. 2'-Substituted-spiro[benzofuran-2(3H),1'-cyclohexanes] and its pharmaceutical use
US4426380A (en) * 1981-10-28 1984-01-17 Ciba-Geigy Corporation Benzofuran-2-ones and pharmaceutical compositions
EP0106800A1 (de) * 1982-10-08 1984-04-25 Ciba-Geigy Ag Furane
US4863958A (en) * 1984-06-20 1989-09-05 Merck Frosst Canada, Inc. Benzofuran derivatives useful as inhibitors of mammalian leukotriene biosynthesis
JPS6133183A (ja) * 1984-07-25 1986-02-17 Mitsubishi Chem Ind Ltd ２，３−ジヒドロ−７−アミノベンゾフランの製造法
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
US5366986A (en) * 1988-04-15 1994-11-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
US5506247A (en) * 1988-04-15 1996-04-09 T Cell Sciences, Inc. Compounds that inhibit complement and/or suppress immune activity
US5173499A (en) * 1988-04-15 1992-12-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
CA2097825A1 (en) * 1990-12-06 1992-06-07 Henry C. Marsh, Jr. Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU564232B2 (en) * 1981-10-19 1987-08-06 Hoechst-Roussel Pharmaceuticals Inc. 2:-substituted-spiro benzofuran(2,1:) cycloalkanes
AU6234486A (en) * 1985-09-05 1987-03-12 Hoechst-Roussel Pharmaceuticals Inc. Spiro(benzofuran-2(3h), 1'-cycloheptane)s
AU605818B2 (en) * 1986-12-27 1991-01-24 Takeda Chemical Industries Ltd. Coumarane derivatives, their production and use

Also Published As

Publication number Publication date
KR930702893A (ko) 1993-11-29
KR100187327B1 (ko) 1999-05-01
WO1992010096A1 (en) 1992-06-25
US5656659A (en) 1997-08-12
US5366986A (en) 1994-11-22
EP0561989A1 (en) 1993-09-29
EP0561989A4 (enExample) 1994-03-09
AU9127491A (en) 1992-07-08
CA2097826A1 (en) 1992-06-07
JPH06503829A (ja) 1994-04-28

Similar Documents

Publication Publication Date Title
AU9127491A (en) Compounds that inhibit complement and/or suppress immune activity
US5808109A (en) Compounds that inhibit complement and/or suppress immune activity
US5866545A (en) Substituted ketone derivatives as inhibitors of interleukin-1β converting enzyme
AU712241B2 (en) Immunosuppressive compounds and methods
Vargaftig et al. PAF-acether today—relevance for acute experimental anaphylaxis
US5827868A (en) Prostaglandin analogs
US6451796B1 (en) Fused pyrazine compounds
EP1176134A1 (en) Ligands of nuclear receptors ppar's
US5962516A (en) Immunosuppressive compounds and methods
JP3940810B2 (ja) アデノシンモノホスフェートデアミナーゼの新規阻害剤
AU9149791A (en) Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
JP4372843B2 (ja) 坑腫瘍剤として有用なイルジン類似体
EP1369419B1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
US5401767A (en) Compounds which inhibit complement and/or suppress immune activity
AU2005218610A1 (en) Triptolide lactone ring derivatives as immunomodulators and anticancer agents
JP2000319278A (ja) 縮合ピラジン化合物およびその化合物を有効成分とする薬剤
PT865428E (pt) Analogos de vitamina d
FR2521992A1 (fr) Nouveaux composes de pyridine utiles comme medicaments
HU187318B (en) Process for preparing hetero-imino-prostacyclin derivatives
US3455946A (en) 5-(ortho-alkenyloxyphenoxymethyl)-oxazolidinone-2-compounds
US3836656A (en) Substituted purines as hypolipidemics
US4163016A (en) 16-Substituted prostaglandins
KR100311852B1 (ko) 포스포노메틸디펩타이드,이의제조방법및이를포함하는약제학적조성물
US4510159A (en) (+)-Cyanidan-3-ol derivatives, pharmaceutical preparations that contain such compounds, and the use of the latter to treat liver or venous diseases
US4258053A (en) Thienyl-prostaglandins and process for their manufacture

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired